Post Acute Sequelae Covid-19 Hyposmia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Post Acute Sequelae Covid-19 Hyposmia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT05970731

Directed Topical Drug Delivery for Treatment for PASC Hyposmia

This is a phase II randomized, double-blinded, placebo-controlled study to evaluate the efficacy of topical intranasal treatment of beclomethasone vs. placebo f…

United States16 participantsStarted 2023-09-05

Treatment: Beclomethasone, Placebo